Spyre Therapeutics, Inc. (SYRE)
42.79
+1.54
(+3.73%)
USD |
NASDAQ |
Mar 23, 16:00
42.79
0.00 (0.00%)
After-Hours: 20:00
Spyre Therapeutics EPS Diluted (Quarterly) : -0.6903 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tyra Biosciences, Inc. | -0.5655 |
| Savara, Inc. | -0.1341 |
| Agios Pharmaceuticals, Inc. | -1.852 |
| Tandem Diabetes Care, Inc. | -0.0087 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -51.83M |
| Total Expenses (Quarterly) | 51.83M |
| Enterprise Value | 2.639B |
| Earnings Yield | -4.86% |
| Normalized Earnings Yield | -5.073 |